Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.
| 1M | 3M | 6M | 1Y p.a. | 2Y p.a. | 3Y p.a. | 5Y p.a. | 10Y p.a. | |
| Total return | -2.98% | -4.44% | -3.26% | 0.81% | -3.12% | -9.66% | -% | -% |
| Growth return | -2.98% | -4.44% | -3.26% | 0.81% | -3.12% | -9.7% | -% | -% |
| Income return | 0% | 0% | 0% | 0% | 0% | 0.04% | -% | -% |
|
Market index (MSCI USA NR AUD)
|
||||||||
| Total return | -1.68% | 1.7% | 8.64% | 8.92% | 22.29% | 23.42% | 16.74% | 15.22% |
| Type | Description |
| Challenger - GMO US Core | |
| Closed | |
| Fidante Partners Limited | |
| HOW0108AU | |
| Equity North America | |
| Not Rated | |
| Investment Fund | |
| 31 May 2001 | |
| $0.04 million (as at 28 Feb 2002) | |
| $17.7064 (as at 1 Nov 2004) | |
| $17.49 (as at 1 Nov 2004) | |
| Finalised |
| Type | Description |
| Minimum initial investment | $5,000.00 |
The objective of the Challenger - GMO US Core managed fund is To seek high total return. The current benchmark is the S&P 500 Index.
The strategy of the Challenger - GMO US Core managed fund is Invests primarily in the equity securities of at least 125 companies chosen from amongst 600 companies with the largest equity capitalisation and whose securities are listed on the US national securities exchange. The Fund may use derivatives to hedge against the economic impact of adverse changes in the market value of portfolio securities, as a substitute for buying or selling securities or for risk management. Normally, at least 65% of the Fund's assets will be invested in ordinary shares of US issuers.
The APIR code of the Challenger - GMO US Core managed fund is HOW0108AU.
Challenger - GMO US Core’s total return last month was -2.98%. This was made up of a growth return of -2.98% and an income return of 0%. These returns were calculated as at 31 Oct 2004.
Challenger - GMO US Core’s total return for the last three months was -4.44%. This was made up of a growth return of -4.44% and an income return of 0%%. These returns were calculated as at 31 Oct 2004.
Challenger - GMO US Core’s one-year total return is 0.81%. This was made up of a growth return of 0.81% and an income return of 0%. These returns were calculated as at 31 Oct 2004.
Challenger - GMO US Core’s one-year total return is -9.66%. This was made up of a growth return of -9.7% and an income return of 0.04%. These returns were calculated as at 31 Oct 2004.
The asset allocation of the Challenger - GMO US Core managed fund is :
The Responsible Entity for the Challenger - GMO US Core managed fund is Fidante Partners Limited.
The Challenger - GMO US Core managed fund belongs to the Equity North America sector/asset class.
As at 28 Feb 2002, the size of the Challenger - GMO US Core managed fund was $0.04 million.
The Challenger - GMO US Core managed fund has an inception date of 31 May 2001.
The current entry price of the Challenger - GMO US Core managed fund is $17.7064 per unit and the current exit price is $17.49 per unit (as at 1 Nov 2004).
The current exit price of the Challenger - GMO US Core managed fund is $17.49 per unit and the current entry price is $17.7064 per unit (as at 1 Nov 2004).
The minimum initial investment amount for the Challenger - GMO US Core managed fund is $5,000.
Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.